8-K: LanzaTech Extends Financing Deadline, Plans Reverse Split

Sentiment:

Amendment to Financing Agreement


LanzaTech Global, Inc. has amended its preferred stock purchase agreement, extending the deadline for a subsequent financing to October 15, 2025, and clarifying terms for a potential 100:1 reverse stock split.

Delay expectedThe deadline for the 'Subsequent Financing' has been extended to October 15, 2025, from an unspecified prior date.The Purchaser waived the Company's obligation to file a registration statement by an earlier deadline, effectively delaying that filing until 10 business days following the issuance of Warrant Shares.
Capital raiseThe company is planning a 'Subsequent Financing' to sell common stock to one or more accredited investors.The financing aims to raise an aggregate original issue price of not less than $35,000,000 and not more than $60,000,000.The common stock will be sold at a price of $5.00 per share, after giving effect to a 100:1 reverse stock split.The deadline for this financing has been extended to October 15, 2025, and multiple financing closings are permitted.
Worse than expectedThe necessity of a significant capital raise (Subsequent Financing) suggests ongoing funding requirements and potential cash flow challenges.The proposed 100:1 reverse stock split is an extreme measure typically indicative of a severely depressed stock price, often used to avoid delisting or to make the stock appear more attractive, but it generally signals underlying financial distress.The extension of the financing deadline implies that the company has not yet secured the necessary capital under previous terms, which can be a negative signal regarding investor confidence or market conditions.

Summary

  • Amended the Series A Convertible Senior Preferred Stock Purchase Agreement (Purchase Agreement) and the Amended and Restated Certificate of Designation (CoD Amendment) on September 22, 2025.
  • Extended the deadline for a 'Subsequent Financing' to October 15, 2025, and permitted multiple financing closings.
  • The Subsequent Financing aims to raise between $35,000,000 and $60,000,000 by selling common stock to accredited investors at a price of $5.00 per share (after giving effect to a reverse stock split).
  • Clarified 'Requisite Stockholder Approval' to include Nasdaq Stockholder Approval and company stockholder approval for amendments to the Certificate of Incorporation.
  • These amendments authorize sufficient common stock for transactions contemplated by the Purchase Agreement, warrant exercise, and the Subsequent Financing.
  • The amendments also set the common stock par value to the warrant exercise price and effect a 100:1 reverse stock split with a corresponding decrease in the number of authorized shares of common stock.
  • LanzaTech Global SPV, LLC (the Purchaser) waived the Company's obligation to file a registration statement by an earlier deadline, agreeing to a new deadline of 10 business days following the issuance of Warrant Shares.

Sentiment

Score: 3

Explanation: While the extension of the financing deadline and the waiver provide some operational flexibility, the necessity of a 100:1 reverse stock split and the ongoing need for significant capital raise indicate underlying financial challenges and a severely depressed stock price, which are generally negative signals for investors.

Positives

  • Secured an extension for the Subsequent Financing deadline to October 15, 2025, providing more time to raise capital.
  • The allowance for multiple closings in the Subsequent Financing offers increased flexibility in capital raising.
  • Clarified stockholder approval requirements for key corporate actions, potentially streamlining future processes.
  • The waiver from the Purchaser provides the Company with more flexibility regarding the registration statement filing timeline.

Negatives

  • The necessity of a 100:1 reverse stock split typically indicates a severely depressed stock price and can be viewed negatively by the market.
  • The ongoing need for a significant capital raise (Subsequent Financing) suggests persistent funding requirements.
  • The extension of the financing deadline implies that the company has not yet secured the necessary capital under previous terms, potentially signaling challenges in attracting investors.

Risks

  • Failure to complete the Subsequent Financing by the extended deadline of October 15, 2025, could significantly impact the company's liquidity and operational capabilities.
  • There is a risk that the company may not obtain the requisite stockholder approvals for the reverse stock split and increased authorized shares, which are critical for the Subsequent Financing.
  • A 100:1 reverse stock split, while intended to increase share price, carries the risk of further share price decline post-split and may not improve market perception or liquidity.
  • The company faces the challenge of attracting accredited investors for the Subsequent Financing at the specified price of $5.00 per share (post-split).

Future Outlook

The company is actively pursuing a Subsequent Financing to raise between $35 million and $60 million by October 15, 2025, through the sale of common stock at $5.00 per share (post-reverse stock split). This financing is contingent on obtaining requisite stockholder approvals for a 100:1 reverse stock split and an increase in authorized common stock.

Management Comments

  • The Board of Directors, acting in accordance with the provisions of Sections 141(f) and 242 of the DGCL, duly adopted resolutions to amend the Certificate of Designation, declaring the proposed amendment to be advisable.

Industry Context

NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Certificate of DesignationAmended Section 12 of the Certificate of Designation to redefine 'Requisite Stockholder Approval' and 'Subsequent Financing'. This includes requirements for Nasdaq approval and company stockholder approval for increased authorized common stock, par value adjustment, and a 100:1 reverse stock split.September 22, 2025Clarifies and formalizes the requirements for critical corporate actions, particularly those related to capital structure and future financing, ensuring compliance and shareholder consent.

Related Party Transactions

  • The Series A Convertible Senior Preferred Stock Purchase Agreement and its amendments are with LanzaTech Global SPV, LLC, an entity controlled by an existing investor.
  • The Waiver Agreement is also between the Company and LanzaTech Global SPV, LLC.

Stakeholder Impact

  • Shareholders will experience a 100:1 reverse stock split, which will consolidate their shares and proportionally increase the price per share. The Subsequent Financing could lead to dilution for existing common shareholders if they do not participate.
  • LanzaTech Global SPV, LLC, as the Purchaser and a related party, has agreed to the amendments and waiver, indicating continued engagement and support for the company's capital-raising efforts, albeit with adjusted terms.

Next Steps

  • Complete the Subsequent Financing by October 15, 2025.
  • Obtain Nasdaq Stockholder Approval for the proposed corporate actions.
  • Obtain requisite Company stockholder approval for amendments to the Certificate of Incorporation, including authorization for sufficient common stock, setting par value, and effecting a 100:1 reverse stock split.
  • File the Registration Statement no later than 10 business days following the issuance of Warrant Shares.

Key Dates

DateDescription
January 28, 2021Original Certificate of Incorporation filed with the Office of the Secretary of State of the State of Delaware.
August 3, 2021First Amended and Restated Certificate of Incorporation filed.
February 8, 2023Second Amended Restated Certificate of Incorporation filed.
October 3, 2024Certificate of Amendment to Second Amended Restated Certificate of Incorporation filed.
May 7, 2025Series A Convertible Senior Preferred Stock Purchase Agreement entered into; Certificate of Designation of Series A Convertible Senior Preferred Stock filed.
May 31, 2025Registration Rights Agreement modified.
June 2, 2025Amendment No. 1 to Series A Convertible Senior Preferred Stock Purchase Agreement dated; Amended and Restated Certificate of Designation filed.
July 28, 2025Company's annual meeting of shareholders held.
August 15, 2025Certificate of Amendment to Second Amended Restated Certificate of Incorporation filed (effective 4:59 p.m. Eastern Time on August 18, 2025).
August 15, 2025Certificate of Amendment to Second Amended Restated Certificate of Incorporation filed (effective 5:00 p.m. Eastern Time on August 18, 2025).
August 15, 2025Restated Certificate of Incorporation filed (effective 5:01 p.m. Eastern Time on August 18, 2025).
September 20, 2025Board of Directors adopted resolutions to amend the Certificate of Designation.
September 22, 2025Amendment No. 2 to Series A Convertible Senior Preferred Stock Purchase Agreement entered into; Certificate of Amendment to Amended and Restated Certificate of Designation filed; Waiver Agreement effective date.
September 26, 2025Waiver Agreement entered into; 8-K report signed.
October 15, 2025New deadline for completion of the Subsequent Financing.

Recommendation

sell

The filing reveals significant red flags for investors. The proposed 100:1 reverse stock split is an extreme measure typically indicative of a severely distressed stock price and often fails to sustainably improve market perception or liquidity. While the extension of the financing deadline provides a temporary reprieve, the ongoing need for a substantial capital raise ($35M-$60M) at a post-split price of $5.00, coupled with the magnitude of the reverse split, suggests fundamental challenges in the company's valuation and financial health. These actions are generally viewed negatively by the market and often precede further share price erosion. A seasoned investor would likely view these developments as a strong signal to exit their position.

Keywords

LanzaTech Global, LNZA, SEC Filing, 8-K, Convertible Preferred Stock, Subsequent Financing, Reverse Stock Split, Capital Raise, Stockholder Approval, Registration Rights, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.